MEDICAL INTERNATIONAL TECHNOLOGY

As of June 30, 2016, MEDICAL INTERNATIONAL TECHNOLOGY carries a market capitalization of 261,344.34, placing it among publicly traded companies globally. Its enterprise value stands at 170,637.34, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2016, MEDICAL INTERNATIONAL TECHNOLOGY has 84.30M shares outstanding.

These figures are as of June 30, 2016. The price-to-sales ratio is 0.66, and the price-to-book ratio stands at -5.00.

These figures are as of June 30, 2016. The EV/Sales ratio of 0.43 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 170,637.34 versus a market cap of 261,344.34, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2016, MEDICAL INTERNATIONAL TECHNOLOGY maintains a current ratio of 0.76, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -590.09, indicating conservative leverage, while an interest coverage ratio of -21.86 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2016. Return on assets (ROA) is negative at -58.86, reflecting losses generated across the asset base. The company generates approximately 56,813.14 in revenue per employee across its workforce of 7.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.17 indicates how many times MEDICAL INTERNATIONAL TECHNOLOGY sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on August 6, 2026, MEDICAL INTERNATIONAL TECHNOLOGY's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

Over the twelve months ended June 30, 2016, MEDICAL INTERNATIONAL TECHNOLOGY generated 397,692.00 in revenue and converted that into -409,641.00 in net income, yielding earnings per share of 0.00. EBITDA reached -301,365.00, while operating income came in at -395,668.00.

As of June 30, 2016, MEDICAL INTERNATIONAL TECHNOLOGY holds 399,184.00 in cash and equivalents against 308,477.00 in total debt, resulting in a net debt position of -90,707.00. Total book value stands at -52,276.00, with working capital of -210,981.00 providing operational flexibility.

MEDICAL INTERNATIONAL TECHNOLOGY produced -295,071.00 in operating cash flow over the twelve months ended June 30, 2016. After subtracting -43,647.00 in capital expenditures, free cash flow totaled -338,718.00 - equivalent to 0.00 per share.

Over the twelve months ended June 30, 2016, MEDICAL INTERNATIONAL TECHNOLOGY posted a gross margin of 20.66, reflecting its pricing power and cost economics. The operating margin of -99.49 and net profit margin of -103.00 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2016. Free cash flow yield is negative at -129.61: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -257.89, meaning MEDICAL INTERNATIONAL TECHNOLOGY raised more capital through share issuance and new debt than it returned via dividends and buybacks.

MEDICAL INTERNATIONAL TECHNOLOGY's most recent stock split took place on November 21, 2005 with a 10:1 split ratio.

As of June 30, 2016, MEDICAL INTERNATIONAL TECHNOLOGY has an Altman Z-Score of -24.35, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.